AU StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Argent BioPharma Limited

0.160

-0.020-11.11%

Volume:30.44K

Turnover:5.06K

Market Cap:9.48M

PE:-0.36

High:0.180

Open:0.180

Low:0.160

Close:0.180

Loading ...

Overview Company News Filings

Argent BioPharma Working With European Pharmaceutical Manufacturer on Cannabinoid Therapies; Shares Rise 17%

MT Newswires Live

Argent BioPharma signs manufacturing partnership with ECCPharm for emerging cannabinoid therapies

BRIEF-Argent Biopharma Announces Strategic Partnership With ECCPharm

BUZZ-Australia's Argent BioPharma rises on partnership with ECCPharm

Argent Biopharma Ltd - Eccpharm to Provide Gmp Manufacturing for Argent Biopharma

THOMSON REUTERS

BRIEF-Argent BioPharma Posts HY Net Loss Attributable A$12.2 Million

Argent Biopharma - Hy Net Loss Attributable a$12.2 Mln

THOMSON REUTERS

Argent Biopharma Ltd. Updates on Sintef Collaboration for Chronic Wound Management

THOMSON REUTERS

Argent BioPharma Ltd. Updates on SINTEF Collaboration for Chronic Wound Management

Argent BioPharma: A Hidden Gem traded Under $12M--Edison Group Report Assigned a $327M Valuation to Its Breakthrough Epilepsy Treatment

Sparc fires up following three-way hydrogen tie-in

The Sydney Morning Herald

Argent BioPharma Completes $4.5 Million Placement; Shares Up 47%

MT Newswires Live

BUZZ-Australia's Argent BioPharma rises most in over 3 months on premium capital raising

Argent Biopharma Ltd. Placing to Raise US$4,500,000

THOMSON REUTERS

Argent BioPharma Files Trading Halt Ahead of Capital Raise

MT Newswires Live

BRIEF-Argent Biopharma Seeks Trading Halt

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/RGT.AU/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"RGT.AU"},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"RGT.AU\",,,,,undefined,":{"symbol":"RGT.AU","market":"AU","secType":"STK","nameCN":"Argent BioPharma Limited","latestPrice":0.16,"timestamp":1741225274503,"preClose":0.18,"halted":0,"volume":30439,"delay":0,"changeRate":-0.111111,"change":-0.02,"floatShares":14793190,"shares":59272269,"eps":-0.44518,"lyrEps":-0.47364,"pbRate":-0.87,"amount":5064,"amplitude":0.111111,"volumeRatio":0.777623,"dividePrice":0,"prevYearClose":0.17,"fiveDayClose":0.14,"twentyDayClose":0.14},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"RGT.AU\",,,,,undefined,":{"symbol":"RGT.AU","floatShares":14793190,"roa":"-121.60%","roe":"--","lyrEps":-0.47364,"volumeRatio":0.777623,"shares":59272269,"dividePrice":0,"high":0.18,"amplitude":0.111111,"preClose":0.18,"low":0.16,"week52Low":0.12,"pbRate":"-0.87","psRate":"32.06","week52High":0.57,"institutionHeld":0,"latestPrice":0.16,"committee":-0.001553,"eps":-0.44518,"divideRate":0,"volume":30439,"delay":0,"ttmEps":-0.44518,"open":0.18,"prevYearClose":0.17,"prevWeekClose":0.125,"prevMonthClose":0.125,"prevQuarterClose":0.17,"fiveDayClose":0.14,"twentyDayClose":0.14,"sixtyDayClose":0.205},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/RGT.AU\",params:#limit:5,,,undefined,":[{"market":"AU","date":"2024-09-23","symbol":"RGT.AU","reason":null,"defaultRemindTime":1727049600000,"announcedDate":"2024-08-15","type":"delisting","dateTimestamp":1727013600000}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"RGT.AU\",market:\"AU\",,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"RGT.AU\",pageSize:16,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2517951651","title":"Argent BioPharma Working With European Pharmaceutical Manufacturer on Cannabinoid Therapies; Shares Rise 17%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517951651","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517951651?lang=en_us&edition=fundamental","pubTime":"2025-03-05 12:26","pubTimestamp":1741148769,"startTime":"0","endTime":"0","summary":"Argent BioPharma  is working with European pharmaceutical manufacturer ECCPharm, according to a Wednesday filing with the Australian bourse.Under the agreement, ECCPharm will handle manufacturing and batch release responsibilities for Argent's cannabinoid therapies, CannEpil and CogniCann, ensuring access to these therapies through early patient programs in European countries, including Ireland, the UK, and Germany, the filing said.As part of the deal, ECCPharm will oversee the transfer of manufacturing operations from Argent BioPharma's current facilities to ECCPharm's production facility in North Macedonia, the filing added.Argent will cover all costs associated with the technology transfer and retain ownership of its research and development pipeline, along with all intellectual property rights.Shares of the company rose past 17% in recent Wednesday trade.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7096","RGT.AU"],"gpt_icon":0},{"id":"2517951197","title":"Argent BioPharma signs manufacturing partnership with ECCPharm for emerging cannabinoid therapies","url":"https://stock-news.laohu8.com/highlight/detail?id=2517951197","media":"Small Caps","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517951197?lang=en_us&edition=fundamental","pubTime":"2025-03-05 09:29","pubTimestamp":1741138194,"startTime":"0","endTime":"0","summary":"Argent BioPharma  has confirmed that pharmaceutical manufacturer ECCPharm will take on full production and release responsibilities for Argent’s emerging cannabinoid therapies under a strategic partnership between the two companies.The agreement will ensure the CannEpil and CogniCann treatments are available under early patient access programs in key European countries including Ireland, the UK and Germany.Argent will retain ownership of all current and future research and development, as well as intellectual property rights, under the partnership.A technology transfer will relocate the products’ official manufacturing base from Argent’s European facilities to ECCPharm’s state-of-the-art facility in North Macedonia at Argent’s expense.The move aims to enhance production efficiency, ensure regulatory compliance and support scalable manufacturing to meet growing global patient demand for high-quality, medical cannabis-based pharmaceuticals.The transfer process will commence immediately, ","market":"hk","thumbnail":"https://cdn.shortpixel.ai/client/w_868,q_lossy,to_auto,ret_wait/https://150309019.v2.pressablecdn.com/wp-content/uploads/2025/03/Argent-Biopharma-ASX-RGT-Strategic-Manufacturing-Partnership-ECCPharm.jpg","type":0,"news_type":0,"thumbnails":["https://cdn.shortpixel.ai/client/w_868,q_lossy,to_auto,ret_wait/https://150309019.v2.pressablecdn.com/wp-content/uploads/2025/03/Argent-Biopharma-ASX-RGT-Strategic-Manufacturing-Partnership-ECCPharm.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://smallcaps.com.au/argent-biopharma-partnership-eccpharm-emerging-cannabinoid-therapies/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"smallcap_stock","symbols":["RGT.AU","BK7096"],"gpt_icon":0},{"id":"2517939026","title":"BRIEF-Argent Biopharma Announces Strategic Partnership With ECCPharm","url":"https://stock-news.laohu8.com/highlight/detail?id=2517939026","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517939026?lang=en_us&edition=fundamental","pubTime":"2025-03-05 09:16","pubTimestamp":1741137374,"startTime":"0","endTime":"0","summary":"BRIEF-Argent Biopharma Announces Strategic Partnership With ECCPharmMarch 5 (Reuters) - Argent BioPharma Ltd RGT.AX:ANNOUNCES STRATEGIC PARTNERSHIP WITH ECCPHARMECCPHARM TO PROVIDE GMP MANUFACTURING FOR ARGENT BIOPHARMAFurther company coverage: RGT.AX ((Reuters.Briefs@thomsonreuters.com;))","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250305:nFWN3PN0OF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RGT.AU","BK7096"],"gpt_icon":0},{"id":"2517960939","title":"BUZZ-Australia's Argent BioPharma rises on partnership with ECCPharm","url":"https://stock-news.laohu8.com/highlight/detail?id=2517960939","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517960939?lang=en_us&edition=fundamental","pubTime":"2025-03-05 09:07","pubTimestamp":1741136831,"startTime":"0","endTime":"0","summary":"BUZZ-Australia's Argent BioPharma rises on partnership with ECCPharm** Shares of Argent BioPharma RGT.AX rise 24.1% to A$0.180** Drug discovery firm says it has entered a strategic manufacturing partn","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250305:nL3N3PO03Z:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RGT.AU","BK7096"],"gpt_icon":0},{"id":"2517987749","title":"Argent Biopharma Ltd - Eccpharm to Provide Gmp Manufacturing for Argent Biopharma","url":"https://stock-news.laohu8.com/highlight/detail?id=2517987749","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517987749?lang=en_us&edition=fundamental","pubTime":"2025-03-05 06:54","pubTimestamp":1741128867,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250304:nFWN3PN0OF:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["RGT.AU","BK7096"],"gpt_icon":0},{"id":"2514314680","title":"BRIEF-Argent BioPharma Posts HY Net Loss Attributable A$12.2 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2514314680","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514314680?lang=en_us&edition=fundamental","pubTime":"2025-02-28 16:19","pubTimestamp":1740730763,"startTime":"0","endTime":"0","summary":"BRIEF-Argent BioPharma Posts HY Net Loss Attributable A$12.2 MillionFeb 28 (Reuters) - Argent BioPharma Ltd RGT.AX:HY NET LOSS ATTRIBUTABLE A$12.2 MILLIONSource text: ID:nASX2LZQkCFurther company coverage: RGT.AX ((Reuters.Briefs@thomsonreuters.com;))","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250228:nFWN3PI2I6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7096","RGT.AU"],"gpt_icon":0},{"id":"2514995063","title":"Argent Biopharma - Hy Net Loss Attributable a$12.2 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2514995063","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514995063?lang=en_us&edition=fundamental","pubTime":"2025-02-28 13:17","pubTimestamp":1740719839,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250228:nFWN3PI2I6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7096","RGT.AU"],"gpt_icon":0},{"id":"2511536038","title":"Argent Biopharma Ltd. Updates on Sintef Collaboration for Chronic Wound Management","url":"https://stock-news.laohu8.com/highlight/detail?id=2511536038","media":"THOMSON REUTERS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2511536038?lang=en_us&edition=fundamental","pubTime":"2025-02-13 06:30","pubTimestamp":1739399402,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250212:nTUA9PCBSM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7096","RGT.AU"],"gpt_icon":0},{"id":"2511253997","title":"Argent BioPharma Ltd. Updates on SINTEF Collaboration for Chronic Wound Management","url":"https://stock-news.laohu8.com/highlight/detail?id=2511253997","media":"PR Newswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2511253997?lang=en_us&edition=fundamental","pubTime":"2025-02-13 06:30","pubTimestamp":1739399400,"startTime":"0","endTime":"0","summary":"Advanced wound care market projected to exceed $15 billion globally by 2030. PERTH, Australia, Feb. 12, 2025 /PRNewswire/ -- Argent BioPharma Ltd.   has made significant progress in its collaboration with SINTEF to enhance antimicrobial therapies for chronic wounds and potential oncologic wound care. The project leverages nano-encapsulation technology to improve drug efficacy and targeted delivery.SINTEF, headquartered in Trondheim, Norway, is an independent research organization founded in 1950 that conducts contract research and development projects.Optimizing Antimicrobial Compounds: The company has advanced its proprietary antimicrobial compounds for nano-encapsulation, improving their targeted drug delivery.Key Research Milestones Achieved: Standardized in vitro assays have been established, Synthetic Wound Fluid  identified as the optimal testing medium, and promising active pharmaceutical ingredients  with pH-dependent antimicrobial activity selected.In the project's first phase","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"yahoofinance_au","url":"https://finance.yahoo.com/news/argent-biopharma-ltd-updates-sintef-223000107.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/argent-biopharma-ltd-updates-sintef-223000107.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance_au","symbols":["RGTLF","BK7054","RGT.AU","SWF.AU","BK7503","BK7096","BK4007"],"gpt_icon":0},{"id":"2509537251","title":"Argent BioPharma: A Hidden Gem traded Under $12M--Edison Group Report Assigned a $327M Valuation to Its Breakthrough Epilepsy Treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=2509537251","media":"PR Newswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2509537251?lang=en_us&edition=fundamental","pubTime":"2025-02-06 05:00","pubTimestamp":1738789200,"startTime":"0","endTime":"0","summary":"For thousands of patients with refractory epilepsy—commonly referred to as drug-resistant epilepsy—the search for effective treatment often feels like navigating an endless maze. These individuals, about 30% of the epilepsy community, live with seizures that persist despite conventional therapies. Now, a groundbreaking solution, CannEpil, is offering hope.Developed by Argent BioPharma Limited, CannEpilis an oral mucosal solution with a high-CBD, low-THC formulation. It is designed to reduce seizure frequency and severity while minimizing psychoactive effects. After years of clinical development, CannEpilis making waves in the UK as part of a movement to transform severe epilepsy treatment.This breakthrough follows GW Pharmaceuticals' $7.2 billion acquisition, highlighting the potential of cannabis-based epilepsy treatments. Argent BioPharma's CannEpilis poised to follow a similar trajectory, offering a novel solution for drug-resistant epilepsy patients worldwide.Additionally, CannEpil","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"yahoofinance_au","url":"https://finance.yahoo.com/news/argent-biopharma-hidden-gem-traded-210000855.html","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/argent-biopharma-hidden-gem-traded-210000855.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance_au","symbols":["RGT.AU","EIX"],"gpt_icon":0},{"id":"2502839668","title":"Sparc fires up following three-way hydrogen tie-in","url":"https://stock-news.laohu8.com/highlight/detail?id=2502839668","media":"The Sydney Morning Herald","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2502839668?lang=en_us&edition=fundamental","pubTime":"2025-01-10 14:09","pubTimestamp":1736489340,"startTime":"0","endTime":"0","summary":"This week the market again encountered a diverse mix of high-flying winners, with those finding favour on the market comprising a new-age hydrogen tech developer, an immune-related disorder biopharma firm, a mining company growing its scandium critical mineral resource and a drug developer joining forces with a Japanese pharmaceutical firm to fight kidney disease.This week’s Bulls N’ Bears ASX Runner of the Week is…","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.smh.com.au/business/companies/sparc-fires-up-following-three-way-hydrogen-tie-in-20250110-p5l3fv.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"smh_stock","symbols":["DXB.AU","AUZ.AU","BK7508","RGT.AU","BK7036","BK7096","BK7504","BK7501","SPN.AU","BK7067","BK7095"],"gpt_icon":0},{"id":"2501243960","title":"Argent BioPharma Completes $4.5 Million Placement; Shares Up 47%","url":"https://stock-news.laohu8.com/highlight/detail?id=2501243960","media":"MT Newswires Live","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2501243960?lang=en_us&edition=fundamental","pubTime":"2025-01-07 12:09","pubTimestamp":1736222945,"startTime":"0","endTime":"0","summary":"Argent BioPharma (ASX:RGT) completed a $4.5 million placement via the subscription of about 11.3 million fully paid ordinary shares at $0.40 per share, according to a Tuesday Australian bourse filing.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["RGT.AU","BK7096"],"gpt_icon":0},{"id":"2501212358","title":"BUZZ-Australia's Argent BioPharma rises most in over 3 months on premium capital raising","url":"https://stock-news.laohu8.com/highlight/detail?id=2501212358","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2501212358?lang=en_us&edition=fundamental","pubTime":"2025-01-07 10:50","pubTimestamp":1736218201,"startTime":"0","endTime":"0","summary":"BUZZ-Australia's Argent BioPharma rises most in over 3 months on premium capital raising ** Shares of Argent BioPharma RGT.AX rise as much as 52.9% to A$0.260, their biggest intraday pct gain since Oct 1, 2024** The clinical-stage biopharma co completes $4.5 mln capital raise at $0.40 per share** Issue price represents a premium of 276.5%, compared with stock's last closing price of A$0.17** Says placement will help advance co's drug development pipeline, with focus on clinical studies for CannEpil - a seizure-control treatment for refractory epilepsy and cerebral palsy** Stock hits its highest level since Dec 2** About 231,485 shares change hands, 13.2 times the 30-day average volume of 17,562 ** Stock fell 64.2% in 2024  ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250107:nL4N3O305G:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RGT.AU","BK7096"],"gpt_icon":0},{"id":"2501261223","title":"Argent Biopharma Ltd. Placing to Raise US$4,500,000","url":"https://stock-news.laohu8.com/highlight/detail?id=2501261223","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2501261223?lang=en_us&edition=fundamental","pubTime":"2025-01-07 04:00","pubTimestamp":1736193613,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250106:nFWN3O22H6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["RGT.AU","BK7096"],"gpt_icon":0},{"id":"2500747136","title":"Argent BioPharma Files Trading Halt Ahead of Capital Raise","url":"https://stock-news.laohu8.com/highlight/detail?id=2500747136","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2500747136?lang=en_us&edition=fundamental","pubTime":"2025-01-03 10:23","pubTimestamp":1735871009,"startTime":"0","endTime":"0","summary":"Argent BioPharma  requested a trading halt for its shares pending a disclosure to be made by the company regarding a capital raise, according to a Friday filing with the Australian bourse.The shares will remain in a trading halt until the announcement is made or the start of normal trading on Jan. 7 or upon the release of the disclosure, the filing said.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7096","RGT.AU"],"gpt_icon":0},{"id":"2500184015","title":"BRIEF-Argent Biopharma Seeks Trading Halt","url":"https://stock-news.laohu8.com/highlight/detail?id=2500184015","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2500184015?lang=en_us&edition=fundamental","pubTime":"2025-01-03 08:33","pubTimestamp":1735864383,"startTime":"0","endTime":"0","summary":"Jan 3 (Reuters) - Argent BioPharma Ltd   :   * SEEKS TRADING HALT PENDING ANNOUNCEMENT ON  CAPITAL RAISING   * SEEKS TRADING HALT PENDING ANNOUNCEMENT ON CAPITAL RAISINGFurther company coverage:    ((Reuters.Briefs@thomsonreuters.com;))","market":null,"thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RGT.AU","BK7096"],"gpt_icon":0}],"pageSize":16,"totalPage":3,"pageCount":1,"totalSize":33}]}}